Home
Categories
Pharmaceutical
Hi Tech Manufacturing
Food
Finance
Design & Build
Containment
Cleaning
Sustainability
HVAC
Personal Protection
Regulatory
CT CONFERENCE
Company News
Events
Directory
Search
Close search
Home
Company
WuXi Biologics
WuXi Biologics
Activities:
Drug Delivery
Pharmaceutical
X
LinkedIn
Trending Articles
What is ISO 8 cleanroom classification?
Each cleanroom class is denoted by a maximum concentration of particles per cubic meter or cubic foot of air. ISO 8 is the second lowest cleanroom classification
Impact of the new Annex 1 on sterile filling in pharma
EU GMP Annex 1 is a whole new era for the sterile filling industry. From barrier technology to “first air”, pharmaceutical manufacturers have a lot to decide. Johannes...
Danish pharmacies invest in hi-tech environmental monitoring system
The construction of a new building prompted one of Denmark’s largest pharmacy businesses to invest in Vaisala’s viewLinc Continuous Monitoring System (CMS) to protect the...
Industry 4.0: What is the advantage of real-time digital signage?
Olivia Fernandez from Digital Therapeutics (DTx) disusses how digital signage can serve in cleanrooms as a versatile and powerful tool that allows those in charge to ensure...
Scientific justification for monitoring indirect product contact surfaces
Findings from a survey on several pharma companies unveil the best practices for monitoring indirect product contact surfaces. Walid El Azab and Lillia Belkhamassi explain
Upcoming event
Clinical Pharmacy Congress
10-11 May 2024 | Conference | London, UK
See all
Related Content
Pharmaceutical
WuXi Biologics plans to build a comprehensive CRDMO centre in Singapore
This investment will establish a cutting-edge, fully integrated CRDMO centre in Singapore and strenghten WuXi Biologics’ global research, development and manufacturing network
Design & Build
WuXi Biologics closes deal to build biomanufacturing hub in the US
China-based WuXi Biologics has agreed to build its 107,000 sqft clinical and commercial manufacturing facility in Worcester, US
Design & Build
WuXi completes weather-tight seal of Irish biologics facility
WuXi Biologics has completed the seal of its first global supply facility in Europe that began construction in February 2019
Design & Build
WuXi invests $240m in Irish CDMO operations
WuXi Vaccines, a subsidiary of China-based WuXi Biologics, will spend $240m to build a dedicated vaccine manufacturing facility
Design & Build
WBDC demolishes hospital for WuXi potential biomanufacturing centre
Worcester Business Development Corp has received $15m from the state to demolish the 380,000 sqft section of a vacant hospital in Massachusetts
Manufacturing
WuXi Biologics CEO: Vaccine CDMO is the next area of growth
Dr Chris Chen launches WuXi Vaccines, announces new facility and a 20-year manufacturing contract worth US$3 billion
Research & Development
Swiss NBE-Therapeutics chooses WuXi Biologics as manufacturing partner
Chinese-Swiss partnership will focus on development and manufacturing capacity of immune-stimulatory ADC treatment against the ROR1 cancer target
Subscribe now